{
  "trial_id": "NCT01011985",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "CKD patients referred for their initial vascular access",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Able to consent for surgery/study",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Active inflammatory states",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Active infection",
      "label": "met",
      "evidence": "quote: \"now resolved after treatment with vanc/meropenem\""
    },
    {
      "criterion": "Autoimmune diseases",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Acute renal allograft rejection",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "HIV positive status",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has a history of CVA, neurogenic bladder with indwelling suprapubic catheter and recurrent UTIs. Urologist not concerned with leaking around suprapubic cath site.",
  "_meta": {
    "topic_id": "13",
    "trial_id": "NCT01011985",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}